首页> 美国卫生研究院文献>Dermatology Research and Practice >A 3-Month Randomized Double-Blind Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair
【2h】

A 3-Month Randomized Double-Blind Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair

机译:为期3个月的随机双盲安慰剂对照研究评估超强海洋蛋白补充剂促进自发稀疏女性头发生长和减少脱落的能力。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An oral marine protein supplement (MPS) is designed to promote hair growth in women with temporary thinning hair (Viviscal Extra Strength; Lifes2good, Inc., Chicago, IL). This double-blind, placebo-controlled study assessed the ability of MPS to promote terminal hair growth in adult women with self-perceived thinning hair associated with poor diet, stress, hormonal influences, or abnormal menstrual cycles. Adult women with thinning hair were randomized to receive MPS (N = 30) or placebo (N = 30) twice daily for 90 days. Digital images were obtained from a 4 cm2 area scalp target area. Each subject's hair was washed and shed hairs were collected and counted. After 90 days, these measures were repeated and subjects completed Quality of Life and Self-Assessment Questionnaires. MPS-treated subjects achieved a significant increase in the number of terminal hairs within the target area (P < 0.0001) which was significantly greater than placebo (P < 0.0001). MPS use also resulted in significantly less hair shedding (P = 0.002) and higher total Self-Assessment (P = 0.006) and Quality of Life Questionnaires scores (P = 0.035). There were no reported adverse events. MPS promotes hair growth and decreases hair loss in women suffering from temporary thinning hair. This trial is registered with ClinicalTrials.gov Identifier: .
机译:口服海洋蛋白补充剂(MPS)旨在促进头发暂时稀疏的女性的头发生长(Viviscal Extra Strength; Lifes2good,Inc.,芝加哥,伊利诺伊州)。这项双盲,安慰剂对照的研究评估了MPS促进成年女性头发终末生长的能力,这些成年女性因饮食不良,压力,荷尔蒙影响或月经周期异常而自我变薄。头发稀疏的成年女性被随机分配接受MPS(N = 30)或安慰剂(N = 30),每天两次,共90天。从4 cm 2 区域头皮目标区域获得数字图像。洗涤每个受试者的头发,并收集脱落的头发并计数。 90天后,重复上述措施,受试者完成了生活质量和自我评估问卷。 MPS治疗的受试者目标区域内的末梢毛发数量显着增加(P <0.0001),显着大于安慰剂(P <0.0001)。使用MPS还可以显着减少脱发(P = 0.002)和更高的总自我评估(P = 0.006)和生活质量问卷得分(P = 0.035)。没有报告不良事件。 MPS可促进头发暂时稀疏的女性的头发生长并减少脱发。该试验已在ClinicalTrials.gov标识符中注册:。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号